Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
FROM THE WIRE · CNBC.COM
Moderna smashed third-quarter revenue and earnings estimates and hiked its outlook for full-year sales growth. The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishThe raised sales growth guidance could support Moderna shares in the biotech sector.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Moderna beat third-quarter revenue and earnings estimates.
- 02It now expects 2026 revenue growth of 15% to 25%.
- 03Previous guidance was for growth of up to 10%.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets